Molecular basis of hyperparathyroidism

Journal of Bone and Mineral Metabolism

Volumn 15, Issue 4, 1997, Pages 173-178

  Tamara, Hideki ^a,b   Arnold, Andrew ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin D1; Multiple endocrine neoplasia; Parathyroid adenoma neoplasia; Parathyroid hormone

Indexed keywords

EID: 0013503352     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02491378     Document Type: Article

References (56)

1. Black WC III, Utley JR (1968) The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol 49:761-775
2. Castleman B, Roth SI (1978) Tumors of the parathyroid glands. In: Hartman WH (ed) Atlas of tumor pathology. 2nd ser. fasc 14. Armed Forces Institute of Pathology, Washington, DC
3. Shane E (1994) Parathyroid carcinoma. In: Bilezikian JP, Marcus R, Levine MA (eds) The parathyroids. Raven, New York, pp 575-581
4. Yoshimoto K, Yamasaki R, Sakai H, Tezuka V, Takahashi M, Iizuka M, Sekiya H, Saito S (1989) Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68:976-981
5. Nussbaum SR, Gaz RD, Arnold A (1990) Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 323 1324-1328
6. Galbraith SC, Quarles LD (1994) Tertiary hyperparathyroidism and refractory secondary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA (eds) The parathyroids. Raven, New York, pp 159-163
7. Fialkow PJ, Jackson CE, Block MA, Greenwald KA (1977) Multicellular origin of parathyroid adenomas. N Engl J Med 277:696-698
8. Jackson CE, Cerny JC, Block MA, Fialkow PJ (1982) Probable clonal origin of aldosteronomas versus multicellular origins of parathyroid adenomas. Surgery 875:875-879
9. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM (1988) Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658-662
10. Cryns VL, Thor A, Xu H-J, Hu S-X, Wierman ME, Vickery AL, Benedict WF, Arnold A (1994) Loss of the retinoblastoma tumor gene in parathyroid carcinoma. N Engl J Med 330:757-761
11. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M (1990) Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968-1972
12. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, McBride WO, Nakamura Y, Brandi ML, Norton JA, Aurbach GD, Spiegel AM, Marx SJ (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type I. N Engl J Med 321:213-218
13. Thakker RV, Bouloux P, Wooding C, Chotal K, Broad PM, Spurr NK, Besser GM, O'Riordan JLH (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321:218-224
14. Arnold A, Brown M, Urena P, Gaz RD, Sarfati E, Drueke T (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053
15. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Bandini S, Marx SJ, Brandi ML (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139-144
16. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350:512-515
17. Hosokawa Y, Arnold A (1996) Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 127:246-252
18. Hsi E, Zukerberg LR, Yang WI, Arnold A (1996) Cyclin D1(PRAD1) expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739
19. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756
20. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavitgian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
21. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y (1994) Frequent somatic mutation of the MTSI/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397
22. Tahara H, Smith AP, Gaz RD, Arnold A (1996) Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. J Clin Endocrinol Metab 81:3663-3667
23. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87
24. Friedman E, De Marco L, Gejman PV, Norton JA, Bale AE, Aurbach GD, Spiegel AM, Marx SJ (1992) Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 52:6804-6809
25. Radford DM, Ashley SW, Wells SA Jr, Gerhard DS (1990) Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res 50:6529-6533
26. Tahara H, Smith AP, Gaz RD, Cryns VL, Arnold A (1996) Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res 56:599-605
27. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A (1995) Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosomes Cancer 13:9-17
28. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699
29. Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524-526
30. Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM (1992) Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52:770-774
31. Mulligan LM, Gardner E, Smith BA, Mathew CGP, Ponder BAJ (1993) Genetic events in tumor initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer 6:166-177
32. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-Keller H (1993) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583
33. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA (1993) Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856
34. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tuuacliffe A, Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
35. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6:70-74
36. Pausova Z, Soliman E, Amizuka N, Janicic N, Konrad EM, Arnold A. Goltzman D, Hendy GN (1996) Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 81:2711-2718
37. Padberg BC, Schroder S, Jochum W, Kastendieck H, Roth J, Heitz PU, Komminoth P (1995) Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol 147:1600-1607
38. Law WM Jr, Heath H III (1985) Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenic studies in 21 families. Ann Intern Med 102:511-519
39. Marx SJ, Attie MF, Levine MA, Speigel AM, Downs RW, Lasker RD (1981) The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 60:397-412
40. Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, Szpirer C, Hendy GN (1995) Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 6:798-801
41. Heath H III, Odelberg S, Brown D, Hill VM, Robertson M, Jackson CE, The BT, Hayward N, Larsson C, Buist N, Garrett J, Leppert M (1994) Sequence analysis of the parathyroid cell calcium receptor (CaR) gene in familial benign hypercalcemia (FBH): a multiplicity of mutations? J Bone Miner Res 9 [suppl 1]:S414
42. Janicic N, Pausova Z, Cole DEC, Hendy GN (1995) Insertion of an Alu sequence in the Ca-sensing receptor gene in familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). Am J Hum Genet 56:880-886
43. Pearce SHS, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, Thakker RV (1995) Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96:2683-2692
44. Pollak MR, Brown EM, Chou YHW, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutations in the human Ca-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303
45. Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108-1112
46. Thompson DB. Samowitz WS, Odelberg S, Davis RK, Szabo J, Heath H III (1995) Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab 80:3377-3380
47. Cryns VL, Arnold A (1995) Frequent allelic loss of chromosome arm 3q DNA in human parathyroid carcinoma. In: Program and abstracts of the 77th annual meeting of the Endocrine Society. Washington, DC, pp 3-506
48. Hosokawa Y, Pollak MR, Brown EM, Arnold A (1995) Mutational analysis of the extracellular Ca-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 80:3107-3110
49. +-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606
50. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Heath H III (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-950
51. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, Goretzki P, Larsson C (1996) Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 81:3194-3196
52. Cryns VL, Rubio MP, Thor AD, Louis DM, Arnold A (1994) p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320-1324
53. Hakim JP, Levine MA (1994) Absence of p53 point mutations in parathyroid adenoma and carcinoma. J Clin Endocrinol Metab 78:103-106
54. Arnold A (1993) Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia. J Clin Endocrinol Metab 77:1108-1112
55. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weiseman J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burn AL, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276:404-407
56. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Scarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burn AL, Marx SJ (1997) Somatic mutations of the MEN1 gene in parathyroid tumours. Nat Genet 16:375-378